These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24827898)

  • 1. Renin-Angiotensin system blockers and cardiovascular death in kidney recipients.
    Opelz G; Döhler B
    Transplantation; 2014 May; 97(10):e62-3. PubMed ID: 24827898
    [No Abstract]   [Full Text] [Related]  

  • 2. Questioning the myth: benefits of renin-angiotensin system blockade in kidney transplant recipients.
    Wong G; Lim WH; Chapman JR
    Transplantation; 2014 Feb; 97(3):271-2. PubMed ID: 24280733
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers.
    Opelz G; Döhler B
    Transplantation; 2014 Feb; 97(3):310-5. PubMed ID: 24492421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heartbeat: Renin-angiotensin system blockade for prevention of cardiovascular disease.
    Otto CM
    Heart; 2017 Sep; 103(17):1305-1307. PubMed ID: 28811285
    [No Abstract]   [Full Text] [Related]  

  • 5. Blockers of the renin-angiotensin-aldosterone system: almost, but not yet, an absolute weapon against cardiovascular and renal diseases!
    Waeber B
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):216. PubMed ID: 22389390
    [No Abstract]   [Full Text] [Related]  

  • 6. Do the benefits of medications outweigh the burdens for hemodialysis patients?: comment on "Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients".
    Johansen KL
    Arch Intern Med; 2012 Apr; 172(7):593-4. PubMed ID: 22493469
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients: a population-based cohort study.
    Bajaj RR; Wald R; Hackam DG; Gomes T; Perl J; Juurlink DN; Manno M; Garg AX; Kitchlu A; Mamdani MM; Yan AT
    Arch Intern Med; 2012 Apr; 172(7):591-3. PubMed ID: 22493468
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis.
    Shen JI; Saxena AB; Montez-Rath ME; Leng L; Chang TI; Winkelmayer WC
    J Nephrol; 2017 Apr; 30(2):281-288. PubMed ID: 27485007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension: are they equivalent?
    Kaplan NM
    J Am Soc Hypertens; 2015 Aug; 9(8):582-3. PubMed ID: 26319536
    [No Abstract]   [Full Text] [Related]  

  • 11. Early inhibition of the renin-angiotensin system improves the long-term graft survival of single pediatric donor kidneys transplanted in adult recipients.
    Zhang R; Laguardia H; Paramesh A; Mills K; Killackey M; McGee J; Alper B; Simon E; Lee Hamm L; Slakey D
    Transpl Int; 2013 Jun; 26(6):601-7. PubMed ID: 23506676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
    Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H
    Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Be careful when combining ACE inhibitors and angiotensin receptor blockers].
    Markun S
    Praxis (Bern 1994); 2013 May; 102(11):689-90. PubMed ID: 23692910
    [No Abstract]   [Full Text] [Related]  

  • 14. Dual blockade of the renin-angiotensin system with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs).
    Ritter JM
    Br J Clin Pharmacol; 2011 Mar; 71(3):313-5. PubMed ID: 21284691
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of the renin-angiotensin-aldosterone system: how to obtain this.
    Pende A; Montecucco F
    Curr Pharm Des; 2012; 18(7):950-1. PubMed ID: 22283769
    [No Abstract]   [Full Text] [Related]  

  • 16. An update of the blockade of the renin angiotensin aldosterone system in clinical practice.
    Márquez DF; Ruiz-Hurtado G; Ruilope LM; Segura J
    Expert Opin Pharmacother; 2015; 16(15):2283-92. PubMed ID: 26389772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium depletion in patients in clinical trials may account for the increased cardiovascular risk of dual blockade of the renin-angiotensin system.
    Laragh JH; Sealey JE
    BMJ; 2013 Mar; 346():f1685. PubMed ID: 23512453
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of renin-angiotensin system inhibitors on mortality and major cardiovascular endpoints in hypertension: A number-needed-to-treat analysis.
    Brugts JJ; van Vark L; Akkerhuis M; Bertrand M; Fox K; Mourad JJ; Boersma E
    Int J Cardiol; 2015 Feb; 181():425-9. PubMed ID: 25569271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine renin-angiotensin system blockade in renal transplantation?
    Remuzzi G; Perico N
    Curr Opin Nephrol Hypertens; 2002 Jan; 11(1):1-10. PubMed ID: 11753080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitor or Angiotensin receptor blocker use and renal outcomes-reply.
    Hsu CC; Liu JS; Tarng DC
    JAMA Intern Med; 2014 Oct; 174(10):1706-7. PubMed ID: 25285739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.